Superworth

Geron EPS GERN

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.10
Latest quarter, Q2 FY26
−$0.02
Fiscal year 2025
−$0.12

Geron's earnings per share was −$0.10 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.02.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.12n/a
FY2024−$0.27n/a
FY2023−$0.33n/a
FY2022−$0.37n/a
FY2021−$0.36n/a
FY2020−$0.27n/a
FY2019−$0.36n/a
FY2018−$0.15n/a
FY2017−$0.18n/a
FY2016−$0.18n/a
FY2015$0.00n/a
FY2014−$0.24n/a
FY2013−$0.29n/a
FY2012−$0.54n/a
FY2011−$0.78n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.02n/a−$0.10
Q1 FY26−$0.01n/a−$0.10
Q4 FY25−$0.04n/a−$0.12
Q3 FY25−$0.03n/a−$0.12
Q2 FY25−$0.02n/a−$0.13
Q1 FY25−$0.03n/a−$0.21
Q4 FY24−$0.04n/a−$0.27
Q3 FY24−$0.04n/a−$0.32
Q2 FY24−$0.10n/a−$0.36
Q1 FY24−$0.09n/a−$0.35
Q4 FY23−$0.09n/a−$0.33
Q3 FY23−$0.08n/a−$0.35

Against its peers

Companies in Drug Manufacturers - General nearest Geron's size, closest first, today.

CompanyEPS, 12 monthsGrowth
GERNGeron−$0.10
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
ARVNArvinas$0.16
OMEROmeros$1.52
PCRXPacira BioSciences$0.35
Peer median$0.85

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Geron

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.